Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in hospital settings.

Takeda withdraws BLA for dengue vaccine

Takeda’s TAK-003 is based on a live-attenuated dengue serotype 2 virus. Credit: Takeda Pharmaceutical Company. Takeda has withdrawn the biologics licence application (BLA) submitted to the US

July 12, 2023

Could Octopuses Arm the Field of Therapeutic RNA Editing?

New research led by Joshua Rosenthal, PhD, of the Marine Biological Laboratory (MBL) and Eli Eisenberg, PhD, at Tel Aviv University, has revealed that octopuses

June 8, 2023

FDA approves Verrica’s skin infection treatment, enters into non-binding term sheet for $125M loan

Verrica Pharmaceuticals’ drug-device combination product is now the first FDA-approved treatment for molluscum contagiosum, a common skin infection. On Friday the FDA approved Ycanth, a

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.